Predictive factors of toxicity of immune checkpoint inhibitors (ICI) in older patients with lung cancer: The ToxImmune study.

被引:0
|
作者
Helissey, Carole
Difoum, Francoise
Vanquaethem, Helene
Vuagnat, Perrine
Picchi, Hugo
Le Roy, Audrey
Schernberg, Antoine
机构
[1] Mil Hosp Begin, Clin Res Unit, St Mande, France
[2] Mil Hosp Begin, St Mande, France
[3] Hop Instruct Armees Begin, St Mande, France
[4] Gustave Roussy, Drug Dev Dept DITEP, Villejuif, France
[5] Mil Hosp Begin, Paris, France
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
12048
引用
收藏
页数:1
相关论文
共 50 条
  • [41] Are immune checkpoint inhibitors (ICI) a valid option for papillary renal cell carcinoma (pRCC)? A multicenter retrospective study.
    De Vries-Brilland, Manon
    Gross-Goupil, Marine
    Boughalem, Elouen
    Beuselinck, Benoit
    Thibault, Constance
    Chevreau, Christine
    Ladoire, Sylvain
    Barthelemy, Philippe
    Negrier, Sylvie
    Borchiellini, Delphine
    Huillard, Olivier
    Geoffrois, Lionnel
    Gravis, Gwenaelle
    Saldana, Carolina
    Thiery-Vuillemin, Antoine
    Seegers, Valerie
    Escudier, Bernard
    Ravaud, Alain
    Albiges, Laurence
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [42] Predictive biomarkers for cancer immunotherapy with immune checkpoint inhibitors
    Bai, Rilan
    Lv, Zheng
    Xu, Dongsheng
    Cui, Jiuwei
    BIOMARKER RESEARCH, 2020, 8 (01)
  • [43] Sequencing chemotherapy and immune checkpoint inhibitors (ICI) in metastatic urothelial carcinoma (UC): Meet-Urol study.
    Bandini, Marco
    Fare, Elena
    Raggi, Daniele
    De Giorgi, Ugo
    Banna, Giuseppe Luigi
    Basso, Umberto
    Losanno, Tania
    Bersanelli, Melissa
    Buti, Sebastiano
    Santini, Daniele
    Mucciarini, Claudia
    Tucci, Marcello
    Tambaro, Rosa
    Farnesi, Azzurra
    Ficorella, Corrado
    Caffo, Orazio
    Naglieri, Emanuele
    Pederzoli, Filippo
    Pignata, Sandro
    Necchi, Andrea
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [44] Remote Exercise Program for Patients with Lung Cancer on Immune Checkpoint Inhibitors
    Bergerot, P. G.
    Bergerot, C. D.
    Silva, J. R. G.
    Farias, J. R.
    Lages, P. S. M.
    Fuzita, W. H.
    Neto, J. N. Matos
    Franca, M. V. D. S.
    Buso, M. M.
    Laloni, M. T.
    Ferreira, C. G.
    William, W. N., Jr.
    Soto-Perez-de-Celis, E.
    Schmitz, K. H.
    Florez, N.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S412 - S412
  • [45] Use of immune checkpoint inhibitors in patients with lung cancer and multiple sclerosis
    Martinez, Belen Iglesias
    Insa, Amelia
    Ygual, Guillermo Cervera
    Gascon, Francisco
    Moran, Jose Andres Dominguez
    Martin-Martorell, Paloma
    LUNG CANCER, 2025, 202
  • [46] Predictive biomarkers for cancer immunotherapy with immune checkpoint inhibitors
    Rilan Bai
    Zheng Lv
    Dongsheng Xu
    Jiuwei Cui
    Biomarker Research, 8
  • [47] IMMUNE CHECKPOINT INHIBITORS AND PROGRESSION OF ATHEROSCLEROSIS AMONG PATIENTS WITH LUNG CANCER
    Drobni, Zsofia
    Taron, Jana
    Gongora, Carlos A.
    Suero-Abreu, Giselle A.
    Karady, Julia
    Leeper, Nicholas James
    Gilman, Hannah
    Sama, Supraja
    Merkely, Bela
    Maurovich-Horvat, Pal
    Foldyna, Borek
    Neilan, Tomas G.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 2379 - 2379
  • [48] Impact of immune checkpoint inhibitors on atherosclerosis progression in patients with lung cancer
    Drobni, Zsofia Dora
    Gongora, Carlos
    Taron, Jana
    Suero-Abreu, Giselle A.
    Karady, Julia
    Gilman, Hannah K.
    Supraja, Sama
    Nikolaidou, Sofia
    Leeper, Nicolas
    Merkely, Bela
    Maurovich-Horvat, Pal
    Foldyna, Borek
    Neilan, Tomas G.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2023, 11 (07)
  • [49] A Review of Cancer Immunotherapy Toxicity: Immune Checkpoint Inhibitors
    Chhabra, Neeraj
    Kennedy, Joseph
    JOURNAL OF MEDICAL TOXICOLOGY, 2021, 17 (04) : 411 - 424
  • [50] A Review of Cancer Immunotherapy Toxicity: Immune Checkpoint Inhibitors
    Neeraj Chhabra
    Joseph Kennedy
    Journal of Medical Toxicology, 2021, 17 : 411 - 424